|
National Institute of Allergy and Infectious Diseases (NIAID) Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified healthcare advice, calls or treatment using a genuine physician. We are not mDs. Always confer with your dr. on National Institute of Allergy and Infectious Diseases (NIAID) clinical studies. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. National Institute of Allergy and Infectious Diseases (NIAID) Clinical research trials and National Institute of Allergy and Infectious Diseases (NIAID) health trials take place in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations like National Institute of Allergy and Infectious Diseases (NIAID) to discover treatments for all forms of conditions. National Institute of Allergy and Infectious Diseases (NIAID) Clinical Trials and other clinical trials allow volunteers to undergo medical treatment alternatives before they are available to the masses. Most times the test subjects undergo professional assistance for free, and every now and again they are paid for their time. Sometimes there is a cost for a National Institute of Allergy and Infectious Diseases (NIAID) clinical trial. Subjects typically get the best healthcare possible for their condition. Risks are a reality, nonetheless, and may include additional or frequent physician trips, medical hazards (perhaps life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "N" Clinical Trials Sponsors > National Institute of Allergy and Infectious Diseases (NIAID) Clinical Trials
National Institute of Allergy and Infectious Diseases (NIAID) Clinical Trials
(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A "Pre-Enrollment" Protocol for HIV-Infected Adolescents
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Blood Test to Look at Cells of the Immune System in Healthy Children
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARC
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Collection of Data from Adult AIDS Clinical Trials
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents with Advanced HIV Disease
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Comparison of HIV-Infected Patients with and without Opportunistic (AIDS-Related) Infection
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected with Both HIV and Hepatitis C Virus (HCV)
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients with AIDS
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Comparison of Two Anti-HIV Treatment Plans
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients with AIDS Who Take Daily Multivitamin and Mineral Supplements
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Comparison of Two Tests for Anti-HIV Drug Resistance
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study)
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Comparison of Zidovudine (AZT) Used Alone or in Combination with Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination with Zidovudine in HIV-1 Infected Children
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis carinii Pneumonia in AIDS
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC.
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients with PGL and/or Constitutional Disease
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With Symptomatic HIV Infection
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNA
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase III Study to Evaluate Corticosteroid-Reduction and -Sparing Effects of Mepolizumab 750 mg Intravenous in Subjects with Hypereosinophilic Syndromes (HES), and to Evaluate the Efficacy and Safety of Mepolizumab in Controlling Clinical Signs and Symptoms of HES Over Nine Months
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Pseudovirion Vaccine
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined with GM-CSF in Healthy, HIV-1 Uninfected Volunteers
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 mcg of gp120 (CHO) BIOCINE in MF59 Emulsion Versus the Emulsion Control: Three Injections at 0, 1, and 6 Months
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Multiclade HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Adult Volunteers
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Evaluation of Azidothymidine (AZT) in Children With Acquired Immune Deficiency Syndrome (AIDS) or AIDS Related Complex (ARC)
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID) Clinical Trials
|
|
|
|
|
|
|
|
